- United States
- /
- Interactive Media and Services
- /
- NasdaqGS:GTM
AI-Powered Copilot Workspace Launch Might Change The Case For Investing In ZoomInfo Technologies (GTM)

Reviewed by Sasha Jovanovic
- ZoomInfo recently unveiled Copilot Workspace, an AI-powered execution engine designed to unify and automate go-to-market operations for sales, account management, and customer success teams by integrating CRM systems and providing real-time, actionable insights.
- This launch addresses high industry inefficiencies and fragmented toolsets, positioning ZoomInfo to help revenue teams streamline demand generation as AI transforms buyer engagement practices.
- We'll examine how Copilot Workspace's unified AI platform could strengthen ZoomInfo's investment case for upmarket enterprise and workflow integration.
Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
ZoomInfo Technologies Investment Narrative Recap
For shareholders, belief in ZoomInfo hinges on organizations continuing to adopt AI-powered platforms to unify sales processes and boost productivity as revenue teams shift from fragmented tools to integrated, proactive solutions. The Copilot Workspace launch solidifies ZoomInfo's positioning in enterprise workflow automation, potentially bolstering its upmarket expansion; however, it does not materially reduce the current risks around customer concentration or the decline in downmarket revenues, both of which are still key short-term concerns.
Among recent company updates, the rollout of API access across Copilot plans in July aligns well with the Workspace launch by increasing data integration and connectivity for enterprise buyers, further supporting ZoomInfo’s catalyst of embedding its platform in client workflows. This, paired with product launches like Copilot Workspace, keeps the focus on growing larger accounts and deepening client stickiness, but the risks tied to reliance on key customers remain salient.
However, investors should also be aware that continuing upmarket expansion brings growing exposure to revenue concentration risk...
Read the full narrative on ZoomInfo Technologies (it's free!)
ZoomInfo Technologies is projected to reach $1.3 billion in revenue and $201.1 million in earnings by 2028. This outlook assumes a 2.8% annual revenue growth rate and an increase in earnings of $111.9 million from the current $89.2 million.
Uncover how ZoomInfo Technologies' forecasts yield a $11.65 fair value, a 14% upside to its current price.
Exploring Other Perspectives
Retail investors in the Simply Wall St Community valued ZoomInfo between US$12.43 and US$21.24, reflecting three differing outlooks. As more enterprise clients adopt integrated platforms, risks tied to customer concentration could carry broader implications for ZoomInfo's earnings stability.
Explore 3 other fair value estimates on ZoomInfo Technologies - why the stock might be worth just $12.43!
Build Your Own ZoomInfo Technologies Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your ZoomInfo Technologies research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
- Our free ZoomInfo Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate ZoomInfo Technologies' overall financial health at a glance.
Contemplating Other Strategies?
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
- AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- Find companies with promising cash flow potential yet trading below their fair value.
- The end of cancer? These 28 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if ZoomInfo Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqGS:GTM
ZoomInfo Technologies
Provides go-to-market intelligence and engagement platform for sales, marketing, operations, and recruiting professionals in the United States and internationally.
Proven track record with moderate growth potential.
Similar Companies
Market Insights
Community Narratives


